Thrombosis and hemostasis biomarkers are biological molecules used to measure the activity of the clotting and anticoagulation systems in the body. These biomarkers are used to diagnose and monitor thrombotic and hemostatic disorders, such as deep vein thrombosis, pulmonary embolism, and stroke. They are also used to assess the risk of thrombotic and hemostatic events in patients with cardiovascular disease. The thrombosis and hemostasis biomarkers market is a rapidly growing segment of the biomarkers industry. It is driven by the increasing prevalence of thrombotic and hemostatic disorders, the growing demand for personalized medicine, and the development of novel biomarkers. Companies in the thrombosis and hemostasis biomarkers market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Thermo Fisher Scientific, and Alere. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
